Viewing Study NCT01579461


Ignite Creation Date: 2025-12-24 @ 12:22 PM
Ignite Modification Date: 2026-01-15 @ 7:41 PM
Study NCT ID: NCT01579461
Status: COMPLETED
Last Update Posted: 2013-09-05
First Post: 2012-04-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Investigate the Effect of Mirabegron (YM178) on Subjects With Mild or Moderate Hepatic Impairment Compared to Healthy Subjects
Sponsor: Astellas Pharma Europe B.V.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module